Form 4: Vivani Medical Director Alexandra Larson Reports Stock Option Grant

Alexandra Larson, a director at Vivani Medical, reported the acquisition of stock options on June 27, 2024, according to a Form 4 filing.

Summary

• Alexandra Larson, a director of Vivani Medical, Inc., filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on June 27, 2024, where Larson acquired 34,839 options to purchase common stock at an exercise price of $1.27.
• These options were granted as part of the Issuer's non-employee director compensation policy.
• The options vest on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, contingent upon continued service.
• A Limited Power of Attorney was also filed, authorizing Adam Mendelsohn, Judy Wong, and Brigid Makes to act on Larson's behalf for SEC filings.

Sentiment

Score: 7

Explanation: The document reflects a routine compensation practice (stock option grant) for a company director, which is generally viewed neutrally to positively as it aligns interests with shareholders.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service by the director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

Stock option grants are a common form of compensation for directors in publicly traded companies, aligning their interests with shareholders and incentivizing company performance.

Comparison to Industry Standards

• Director compensation packages, including stock options, vary widely across the pharmaceutical and medical device industries.
• Companies like Medtronic and Boston Scientific also utilize stock options as part of their director compensation plans.
• The specific number of options granted and the vesting schedule are tailored to the individual company's circumstances and compensation philosophy.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it aligns the director's interests with the company's performance.
• The director is incentivized to contribute to the company's success to increase the value of their options.

Key Dates